This page has been archived on the Web

Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.

Archived

This page has been archived on the Web.

Health product recall

Sodium Bicarbonate Inj 8.4% (2017-06-14)

Starting date:
June 14, 2017
Posting date:
June 19, 2017
Type of communication:
Drug Recall
Subcategory:
Drugs
Hazard classification:
Type I
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-63650

Reason

Product sterility may be compromised in affected lots due to a media fill failure

Depth of distribution

Wholesalers, pharmacies and hospitals across Canada

Affected products

Sodium Bicarbonate Inj 8.4%

DIN, NPN, DIN-HIM

DIN 00261998

Dosage form

Solution

Strength

84 mg/mL

Lot or serial number

  • 72119EV
  • 72120EV

Companies

Recalling Firm
Pfizer Canada Inc.
17300 Trans-Canada Highway
Kirkland
H9J 2M5
Quebec
CANADA
Marketing Authorization Holder
Hospira Healthcare Corporation
17300 Trans-Canada Highway
Kirkland
H9J 2M5
Quebec
CANADA

Report a problem or mistake on this page
What was wrong?

If you want to receive a follow-up reply, please include your name and e-mail address.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Date modified: